imipramine has been researched along with Cancer of Prostate in 5 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Imipramine (IMI), which is a tricyclic antidepressant, has also been shown to has antineoplastic effect." | 1.51 | Effect of Imipramine on radiosensitivity of Prostate Cancer: An In Vitro Study. ( Barlaz Us, S; Comelekoglu, U; Sogut, F; Yalin, S; Yetkin, D; Yildirim, M; Yilmaz, SN, 2019) |
| "11,515 patients with prostate cancer were identified and matched with 55,373 controls." | 1.48 | Prostate cancer and antidepressants: A nationwide population-based nested case-control study. ( Chen, VC; Chiu, WC; Ho, PT; Lin, WY; Lu, ML; McIntyre, RS; Wu, SI; Yim, SJ, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kopp, N | 1 |
| Holtschulte, C | 1 |
| Börgel, F | 1 |
| Lehmkuhl, K | 1 |
| Friedland, K | 1 |
| Civenni, G | 1 |
| Laurini, E | 1 |
| Catapano, CV | 1 |
| Pricl, S | 1 |
| Humpf, HU | 1 |
| Schepmann, D | 1 |
| Wünsch, B | 1 |
| Söğüt, F | 2 |
| Çömelekoğlu, Ü | 2 |
| Dervişoğlu, H | 1 |
| Eroğlu, P | 1 |
| Yalin, S | 2 |
| Yilmaz, NŞ | 1 |
| Barlaz Us, S | 1 |
| Yildirim, M | 1 |
| Yetkin, D | 1 |
| Yilmaz, SN | 1 |
| Lin, WY | 1 |
| Chen, VC | 1 |
| Chiu, WC | 1 |
| Yim, SJ | 1 |
| Ho, PT | 1 |
| McIntyre, RS | 1 |
| Lu, ML | 1 |
| Wu, SI | 1 |
| Puyol, M | 1 |
| Collado, A | 1 |
1 review available for imipramine and Cancer of Prostate
| Article | Year |
|---|---|
[Pharmacological treatment for stress urinary incontinence in prostate cancer].
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic Uptake Inhibitors; Duloxetine Hydroc | 2009 |
4 other studies available for imipramine and Cancer of Prostate
| Article | Year |
|---|---|
Novel σ
Topics: Amination; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cyclohexanes; Human | 2021 |
Effect of imipramine on ether à-go-go potassium channel (Kv1.10) expression in DU145 prostate cancer cells.
Topics: Cell Line, Tumor; Ether; Ether-A-Go-Go Potassium Channels; Humans; Imipramine; Male; Prostatic Neopl | 2022 |
Effect of Imipramine on radiosensitivity of Prostate Cancer: An In Vitro Study.
Topics: Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Ether-A-Go-Go Pota | 2019 |
Prostate cancer and antidepressants: A nationwide population-based nested case-control study.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Case-Control Studies; Correlation of Data; Da | 2018 |